BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 16, 2009
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Chiome Bioscience Inc.

Tokyo, Japan

Technology: ADLib gene conversion antibody generation system

Disease focus: Cancer and immune diseases

Clinical status: Research

Founded: 2005 by...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >